Evolocumab in patients with homozygous familial hypercholesterolemia in India
Open Access
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 15 (6) , 814-821
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
- Amgen
- Novartis
- Bristol-Myers Squibb
- Sanofi
- Boehringer Ingelheim
- Medicines Company
- Pfizer
This publication has 19 references indexed in Scilit:
- Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: Insights from SAFEHEART registryJournal of Clinical Lipidology, 2016
- Phenotype diversity among patients with homozygous familial hypercholesterolemia: A cohort studyAtherosclerosis, 2016
- Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trialThe Lancet, 2015
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyEuropean Heart Journal, 2014
- Current Treatment of Familial HypercholesterolaemiaEuropean Cardiology Review, 2014
- Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial HypercholesterolemiaCirculation, 2012
- Update of Japanese common LDLR gene mutations and their phenotypes: Mild type mutation L547V might predominate in the Japanese populationAtherosclerosis, 2009
- Identification of two new LDL-receptor mutations causing homozygous familial hypercholesterolemia in a South African of Indian originBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Molecular genetics of the LDL receptor gene in familial hypercholesterolemiaHuman Mutation, 1992
- Duplication of seven exons in LDL receptor gene caused by Alu-Alu recombination in a subject with familial hypercholesterolemiaCell, 1987